Bankers Trust’s Myriad Genetics MYGN Stock Holding History

Bankers Trust’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-46,360	Closed	-$973K	–	122
2013 Q4	$973K	Sell	46,360 -584	-1%	-$14.8K	0.61%	67
2013 Q3	$1.1M	Buy	46,944 +8,101	+21%	+$230K	0.78%	54
2013 Q2	$1.04M	Buy	+38,843	New	+$1.13M	0.78%	51

Other funds holding MYGN

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Bankers Trust's MYGN Position: Q1 2014 in Review

Bankers Trust sold out of Myriad Genetics (MYGN) in Q1 2014, closing a stake of 46,360 shares — an estimated $973K sold.

Bankers Trust first reported a position in MYGN in Q2 2013 and held it in 3 quarters. The position peaked at $1.1M in Q3 2013. 281 funds tracked by Wall St. Rank hold MYGN as of Q1 2014.

Bankers Trust reported no remaining Myriad Genetics position as of Q1 2014 after selling out during the quarter.
Bankers Trust sold 46,360 Myriad Genetics shares in Q1 2014, an estimated $973K.
Bankers Trust first reported a position in Myriad Genetics in Q2 2013 and held it in 3 quarters.
Bankers Trust's Myriad Genetics position peaked at $1.1M in Q3 2013.
281 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2014.

Based on Bankers Trust's 13F filing for Q1 2014, filed 15 May 2014.